#BEGIN_DRUGCARD DB04393

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C12H8Cl2O2

# Chemical_IUPAC_Name:
5-chloro-2-(4-chlorophenoxy)phenol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Diclosan

# HET_ID:
DCN

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H8Cl2O2/c13-8-1-4-10(5-2-8)16-12-6-3-9(14)7-11(12)15/h1-7,15H

# InChI_Key:
InChIKey=BYNQFCJOHGOKSS-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4393

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
255.097

# Molecular_Weight_Mono:
253.990134914

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1JW7

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
4.49

# Predicted_LogS:
-3.9

# Predicted_Water_Solubility:
3.27e-02 g/l

# Primary_Accession_No:
DB04393

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
18807

# PubChem_Substance_ID:
46506579

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01135

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC1=C(OC2=CC=C(Cl)C=C2)C=CC(Cl)=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:17 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cell inner membrane
peripheral membrane protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE000511

# Drug_Target_1_GenBank_ID_Protein:
2313282

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
fabI

# Drug_Target_1_Gene_Sequence:
>828 bp
ATGGGATTTTTAAAAGGTAAAAAAGGGCTTATTGTAGGGGTGGCGAACAATAAATCCATC
GCTTATGGGATCGCTCAATCTTGTTTCAATCAAGGGGCTACTTTGGCTTTCACTTATTTG
AATGAGAGTTTAGAAAAGCGCGTAAGGCCTATCGCGCAGGAATTGAATAGCCCCTATGTG
TATGAATTGGATGTGAGCAAAGAAGAGCATTTCAAGTCGCTATACAATAGCGTTAAAAAG
GATTTAGGCTCATTGGATTTTATTGTTCATAGCGTGGCCTTTGCCCCTAAAGAGGCTTTA
GAGGGGAGCTTGTTGGAAACTTCTAAAAGCGCGTTTAACACCGCTATGGAAATTTCTGTT
TATTCTTTAATAGAGCTGACAAACACCCTAAAACCTTTATTGAATAACGGAGCGTCTGTT
TTGACTCTAAGCTATTTGGGTAGCACCAAATACATGGCGCATTACAATGTGATGGGGTTG
GCTAAAGCGGCCCTAGAGAGTGCGGTGCGTTATTTAGCGGTGGATTTAGGCAAACACCAT
ATAAGAGTGAATGCCCTATCGGCCGGGCCTATTAGGACGCTCGCTTCTAGCGGGATCGCT
GATTTTAGAATGATTTTAAAATGGAATGAAATCAACGCCCCTTTAAGAAAAAATGTGAGT
TTAGAAGAAGTGGGCAATGCCGGGATGTATTTGCTCTCTAGTTTGTCTAGCGGGGTGAGT
GGGGAAGTGCATTTTGTGGATGCTGGCTATCATGTTATGGGCATGGGGGCTGTGGAAGAA
AAAGATAATAAAGCTACGCTACTGTGGGATTTGCATAAAGAACAATAA

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
9252185	Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997 Aug 7;388(6642):539-47.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3228

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
29982

# Drug_Target_1_Name:
Enoyl-[acyl-carrier-protein] reductase [NADH]

# Drug_Target_1_Number_of_Residues:
275

# Drug_Target_1_PDB_ID:
1JVF

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Enoyl-[acyl-carrier-protein] reductase [NADH]
MGFLKGKKGLIVGVANNKSIAYGIAQSCFNQGATLAFTYLNESLEKRVRPIAQELNSPYV
YELDVSKEEHFKSLYNSVKKDLGSLDFIVHSVAFAPKEALEGSLLETSKSAFNTAMEISV
YSLIELTNTLKPLLNNGASVLTLSYLGSTKYMAHYNVMGLAKAALESAVRYLAVDLGKHH
IRVNALSAGPIRTLASSGIADFRMILKWNEINAPLRKNVSLEEVGNAGMYLLSSLSSGVS
GEVHFVDAGYHVMGMGAVEEKDNKATLLWDLHKEQ

# Drug_Target_1_Reaction:
acyl-[acyl-carrier-protein] + NAD+ = trans-2,3-dehydroacyl-[acyl-carrier-protein] + NADH + H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Acyl-[acyl-carrier-protein] + NAD(+) = trans- 2,3-dehydroacyl-[acyl-carrier-protein] + NADH

# Drug_Target_1_SwissProt_ID:
O24990

# Drug_Target_1_SwissProt_Name:
FABI_HELPY

# Drug_Target_1_Synonyms:
EC 1.3.1.9
NADH- dependent enoyl-ACP reductase

# Drug_Target_1_Theoretical_pI:
7.80

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04393
